Cover Image
Market Research Report

Europe Blood Market Forecast 2019-2028

Published by Inkwood Research Product code 952504
Published Content info 128 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Blood Market Forecast 2019-2028
Published: August 3, 2020 Content info: 128 Pages
Description

KEY FINDINGS

The Europe blood market is anticipated to register a CAGR of 3.82%, across the forecast years of 2019 to 2028. Factors that promote market growth comprise the upsurge in widespread blood testing and blood screening due to the coronavirus pandemic.

MARKET INSIGHTS

The Europe blood market growth is analyzed through the United Kingdom, Russia, Italy, Poland, Belgium, Germany, France, and the rest of Europe. Italy's blood market is depicting high growth as a result of rapid blood tests conducted during the COVID-19 pandemic. The blood system in the country is a part of the National Health Service. Thus, health care services, including blood and blood component collection, testing, processing, storage, distribution, and transfusion medicine, are delivered by the Regional Health Services, within the national legislative framework. These services define the Ministry of Health's functions, like, coordination, legislation, and supervision.

In Belgium, the spread of the coronavirus has plummeted the country's stocks, due to the cancellation of blood drive events and reduced mobility of would-be-donors. According to health organizations, these events are being called off to minimize the movement of workers and encouraging them to work from home. As a result, the initiative has significantly reduced critical supplies. Thus, the demand for blood screening techniques, and the surge in preventative measures for using blood for transfusion, is projected to bolster the region's market growth.

COMPETITVE INSIGHTS

Major companies operating in the market include, Novo Nordisk A/S, CSL Limited (CSL Behring), Baxter International Inc, Beckton, Dickinson, and Company, Immucor Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32915

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING DEMAND FOR BLOOD AND OTHER BLOOD RELATED PRODUCTS ACROSS THE WORLD
    • 3.2.2. SURGE IN GERIATRIC POPULATION ACROSS THE GLOBE
    • 3.2.3. RISE IN BLOOD DONATIONS AND PLASMA DONATIONS
    • 3.2.4. PROMISING GOVERNMENT REGULATIONS FOR BLOOD SCREENING
    • 3.2.5. PROGRESSION IN BLOOD TRANSFUSION AND BLOOD SCREENING INSTRUMENTS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. HIGH COST OF ADVANCED BLOOD COLLECTION DEVICES
    • 3.3.2. DEARTH OF SKILLED LABORATORY PROFESSIONALS

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. IMPACT OF COVID - BLOOD MARKET

5. MARKET BY PRODUCT

  • 5.1. WHOLE BLOOD COLLECTION
    • 5.1.1. WHOLE BLOOD COLLECTION SYSTEMS
    • 5.1.2. WHOLE BLOOD COLLECTION REAGENTS
  • 5.2. SOURCE PLASMA COLLECTION
    • 5.2.1. SOURCE PLASMA COLLECTION SYSTEMS
    • 5.2.2. SOURCE PLASMA COLLECTION REAGENTS
  • 5.3. BLOOD THERAPEUTICS
    • 5.3.1. INTRAVENOUS IMMUNOGLOBULIN (IVIG)
    • 5.3.2. ALBUMIN
    • 5.3.3. HYPERIMMUNE
    • 5.3.4. FACTOR VIII
    • 5.3.5. FACTOR IX
    • 5.3.6. OTHER BLOOD THERAPEUTICS
  • 5.4. BLOOD TYPING
    • 5.4.1. BLOOD TYPING SYSTEMS
    • 5.4.2. BLOOD TYPING REAGENTS
  • 5.5. BLOOD SCREENING
    • 5.5.1. BLOOD SCREENING SYSTEMS
    • 5.5.2. BLOOD SCREENING REAGENTS
  • 5.6. BLOOD PROCESSING EQUIPMENT
    • 5.6.1. BLOOD PROCESSING EQUIPMENT SYSTEMS
    • 5.6.2. BLOOD PROCESSING EQUIPMENT REAGENTS

6. MARKET BY END-USER

  • 6.1. BLOOD & BLOOD COMPONENT BANKS
  • 6.2. DIAGNOSTIC LABORATORIES
  • 6.3. AMBULATORY SURGICAL CENTERS
  • 6.4. HOSPITALS
  • 6.5. OTHER END-USERS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. EUROPE
    • 7.1.1. UNITED KINGDOM
    • 7.1.2. GERMANY
    • 7.1.3. FRANCE
    • 7.1.4. ITALY
    • 7.1.5. RUSSIA
    • 7.1.6. BELGIUM
    • 7.1.7. POLAND
    • 7.1.8. REST OF EUROPE

8. COMPANY PROFILES

  • 8.1. ABBOTT LABORATORIES
  • 8.2. BIO-RAD LABORATORIES INC
  • 8.3. CSL LIMITED (CSL BEHRING)
  • 8.4. F HOFFMANN-LA ROCHE LTD
  • 8.5. GRIFOLS INTERNATIONAL SA
  • 8.6. HAEMONETICS CORPORATION
  • 8.7. MERCK & CO INC
  • 8.8. NOVO NORDISK A/S
  • 8.9. BAXTER INTERNATIONAL INC
  • 8.10. BECTON DICKINSON AND COMPANY
  • 8.11. FRESENIUS KABI AG
  • 8.12. ORTHO CLINICAL DIAGNOSTICS
  • 8.13. TERUMO CORPORATION (TERUMO BCT INC)
  • 8.14. IMMUCOR INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BLOOD
  • TABLE 2: EUROPE BLOOD MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: EUROPE BLOOD MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: EUROPE BLOOD MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: EUROPE BLOOD MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: EUROPE BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: EUROPE BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019
  • FIGURE 6: EUROPE BLOOD MARKET, BY WHOLE BLOOD COLLECTION, 2019-2028 (IN $ MILLION)
  • FIGURE 7: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY WHOLE BLOOD COLLECTION, IN 2019
  • FIGURE 8: EUROPE BLOOD MARKET, BY WHOLE BLOOD COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: EUROPE BLOOD MARKET, BY WHOLE BLOOD COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: EUROPE BLOOD MARKET, BY SOURCE PLASMA COLLECTION, 2019-2028 (IN $ MILLION)
  • FIGURE 11: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY SOURCE PLASMA COLLECTION, IN 2019
  • FIGURE 12: EUROPE BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 13: EUROPE BLOOD MARKET, BY SOURCE PLASMA COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 14: EUROPE BLOOD MARKET, BY BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 15: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD THERAPEUTICS, IN 2019
  • FIGURE 16: EUROPE BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 17: EUROPE BLOOD MARKET, BY ALBUMIN, 2019-2028 (IN $ MILLION)
  • FIGURE 18: EUROPE BLOOD MARKET, BY HYPERIMMUNE, 2019-2028 (IN $ MILLION)
  • FIGURE 19: EUROPE BLOOD MARKET, BY FACTOR VIII, 2019-2028 (IN $ MILLION)
  • FIGURE 20: EUROPE BLOOD MARKET, BY FACTOR IX, 2019-2028 (IN $ MILLION)
  • FIGURE 21: EUROPE BLOOD MARKET, BY OTHER BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 22: EUROPE BLOOD MARKET, BY BLOOD TYPING, 2019-2028 (IN $ MILLION)
  • FIGURE 23: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD TYPING, IN 2019
  • FIGURE 24: EUROPE BLOOD MARKET, BY BLOOD TYPING SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 25: EUROPE BLOOD MARKET, BY BLOOD TYPING REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 26: EUROPE BLOOD MARKET, BY BLOOD SCREENING, 2019-2028 (IN $ MILLION)
  • FIGURE 27: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD SCREENING, IN 2019
  • FIGURE 28: EUROPE BLOOD MARKET, BY BLOOD SCREENING SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 29: EUROPE BLOOD MARKET, BY BLOOD SCREENING REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 30: EUROPE BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT, 2019-2028 (IN $ MILLION)
  • FIGURE 31: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD PROCESSING EQUIPMENT, IN 2019
  • FIGURE 32: EUROPE BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 33: EUROPE BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 34: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
  • FIGURE 35: EUROPE BLOOD MARKET, BY BLOOD & BLOOD COMPONENT BANKS, 2019-2028 (IN $ MILLION)
  • FIGURE 36: EUROPE BLOOD MARKET, BY DIAGNOSTIC LABORATORIES, 2019-2028 (IN $ MILLION)
  • FIGURE 37: EUROPE BLOOD MARKET, BY AMBULATORY SURGICAL CENTERS, 2019-2028 (IN $ MILLION)
  • FIGURE 38: EUROPE BLOOD MARKET, BY HOSPITALS, 2019-2028 (IN $ MILLION)
  • FIGURE 39: EUROPE BLOOD MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
  • FIGURE 40: EUROPE BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 41: UNITED KINGDOM BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: GERMANY BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 43: FRANCE BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 44: ITALY BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 45: RUSSIA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 46: BELGIUM BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 47: POLAND BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 48: REST OF EUROPE BLOOD MARKET, 2019-2028 (IN $ MILLION)
Back to Top